SCHEMBL7741794

SCHEMBL7741794

C=C1c2cccnc2NC(=O)N1C1CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.45
LMNA P02545 1/20 0.45
POLB P06746 1/20 0.45
ADORA3 P0DMS8 1/20 0.45
MAPK1 P28482 1/20 0.45
ADORA2A P29274 1/20 0.45
ADORA1 P30542 1/20 0.45
PDE3A Q14432 1/20 0.45
CYP1A2 P05177 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
OPRM1 P35372 1/20 0.39
OPRD1 P41143 1/20 0.39
OPRL1 P41146 1/20 0.39
MAPT P10636 2/20 0.36
NPC1 O15118 1/20 0.36
GAA P10253 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
RAB9A P51151 1/20 0.36
MCL1 Q07820 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12462359 0.75 CYP1A2 (0.46) ALDH1A1CYP1A2SMN1; SMN2MAPTNPC1
SCHEMBL16835777 0.67 ALDH1A1 (0.85) ALDH1A1LMNAPOLBADORA3MAPK1
SCHEMBL3728481 0.67 IDH1 (0.43) ENPP1
SCHEMBL9704493 0.67 ALDH1A1 (0.70) ALDH1A1LMNAPOLBADORA3MAPK1
SCHEMBL1364796 0.64 ALDH1A1 (0.62) ALDH1A1LMNAPOLBADORA3MAPK1
SCHEMBL3422239 0.64 CYP1A2 (0.47) ALDH1A1CYP1A2SMN1; SMN2MAPTNPC1
SCHEMBL20218242 0.63 CYP1A2 (0.59) ALDH1A1CYP1A2SMN1; SMN2MAPTNPC1
SCHEMBL22806019 0.63 CYP1A2 (0.59) ALDH1A1CYP1A2SMN1; SMN2MAPTNPC1
SCHEMBL2493976 0.63 CYP1A2 (0.59) ALDH1A1CYP1A2SMN1; SMN2MAPTNPC1
SCHEMBL29759335 0.63 CYP1A2 (0.59) ALDH1A1CYP1A2SMN1; SMN2MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6774134-B2 FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION BRISTOL-MYERS SQUIBB COMPANY 2004-08-10 US disclosed
US-6774134-B2 FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION BRISTOL-MYERS SQUIBB COMPANY 2004-08-10 US disclosed